3 Penny Stocks to Watch in Early July 2022
With a solidly bullish trading day in the books for penny stocks and blue chips, investors are excited about the future right now. With a fourth day of gains for the NASDAQ, many investors are hopeful that we could be seeing the beginnings of more bullish movement in the stock market.
[Read More] Best Penny Stocks to Buy Right Now? 3 to Watch
Now, over the course of the last few months, volatility has been extremely high which has led to large losses for some investors. But, knowing how to make money despite this is crucial to profiting in the long term. With this in mind, let’s take a look at three penny stocks to add to your penny stocks watchlist in July.
3 Penny Stocks to Add to Your July 2022 Watchlist
- Gingko Bioworks Holdings Inc. (NYSE: DNA)
- Globalstar Inc. (NYSE: GSAT)
- HTG Molecular Diagnostics Inc. (NASDAQ: HTGM)
Gingko Bioworks Holdings Inc. (NYSE: DNA)
By EOD, shares of DNA stock of DNA stock had shot up by over 8% to more than $3.24 per share. This is a sizable uptick and comes after a five day uptick of over 30%. This is a significant gain for the company and one that is exciting for investors considering its six month drop of more than 50%.
[Read More] Hot Penny Stocks To Buy? 3 Under $1 To Watch Now
The most recent news from the company came on June 21st when it announced that it and its partner, Cronos Group, achieved a THCV equity milestone. Utilizing Gingko’s platform for development, Cronos was able to achieve a productivity target for this specific cannabinoid. As a result, it shows just how viable Gingko’s product is.
“Working with Cronos to develop innovations in cannabis is an opportunity for us to apply synthetic biology in a way that is helping bring the cannabis industry forward and make a real impact on its market and the customers it serves. The progress we’ve made thus far in our collaboration is a true testament to both the potential of synthetic biology and the world-class teams at Cronos and Ginkgo.”The CEO and Co-Founder of Gingko, Jason Kelly
With all of this exciting news in mind, do you think that DNA stock is worth adding to your list of penny stocks to buy or not?
Globalstar Inc. (NYSE: GSAT)
On July 7th, shares of GSAT stock managed to push up by over 4%. And in the past month, we have seen a small bullish turnaround for GSAT stock, resulting in a respectable, 2% increase. In its six month trading, GSAT has pushed up by over 20%. To understand whether or not Globalstar is worth buying, we have to take a closer look at any recent announcements from it. On June 22nd, the company announced the introduction of its advanced edge platform for use in satellite asset tracking and telematics data.
“This newest innovation from Globalstar represents a continued commitment to IoT as a core business pillar. With Realm Enablement Suite, customers have the flexibility and agility they need to optimize data from their tracking devices and edge sensors.
Generating smart data at the edge for delivery to the customer endpoint makes all the difference in transmission efficiency and operational performance.”The CEO of Globalstar, Dave Kagan
In the past few months, GSAT stock has shown a sizable amount of market popularity. And as a result of this, many investors are keeping a close eye on the company. With this considered, does GSAT belong on your penny stocks watchlist or not?
HTG Molecular Diagnostics Inc. (NASDAQ: HTGM)
One of the larger gainers of the day on July 7th is HTGM stock. At EOD, shares of HTGM stock had climbed by more than 14%. This is an exciting gain for the company and comes after a five day uptick of over 50%. If that seems like a lot, in the past month, HTGM stock has exploded by more than 155%. The most recent news from the company came on July 6th. On July 6th, the company stated that it released its second whitepaper. This concerns its transcriptome-informed drug discovery approach.
“We cannot overstate the need to accelerate the drug discovery process by designing and selecting molecules with greater chances for success, with the goal of allowing new treatments to reach patients as quickly and as efficiently as possible.
We believe the studies outlined in the White Paper further substantiate the power of our transcriptome-informed drug discovery and design platform and the pivotal role it can play in reaching this goal.”The Senior VP of Therapeutics at HTG, Dr. Stephen Barat
As stated earlier, there is a major amount of emphasis on the biotech sector right now. With this considered, does HTGM belong on your buy list or not?
Which Penny Stocks Are You Watching Right Now?
If you’re looking for penny stocks to buy, there are hundreds of options to choose from. Because of this, it all comes down to what you’re looking for and what your investing strategy is.
With that in mind, understanding what is going on in the stock market will also be crucial to your success as a trader. So, considering all of this, which penny stocks are you watching right now?